Abstract Historically, low-carbohydrate (CHO) and very-low-CHO diets have been used for
weight loss. Recently, these diets have been promoted for type 2 diabetes (T2D) …

Highlights•FH is a common inherited autosomal codominant disorder.•Homozygous FH
patients usually have a poor response to traditional lipid-lowering therapy.•We reviewed the …

Background Familial hypercholesterolemia (FH), is a historically underdiagnosed,
undertreated, high‐risk condition that is associated with a high burden of cardiovascular …

Heterozygous familial hypercholesterolemia (FH) represents a strong risk for development of
premature coronary artery disease (CAD). However, the majority of patients with FH are …

Familial hypercholesterolemia (FH) is an autosomal dominant disease mainly caused by
mutations in the low-density lipoprotein receptor (LDLR) gene. FH patients present a wide …

Familial hypercholesterolemia (FH) is associated with a very high risk of cardiovascular
complications and the need for an early aggressive lipid-lowering therapy. The achievement …

Background Familial hypercholesterolemia (FH) is an autosomal dominant dyslipidemia
characterized by defective low-density lipoprotein (LDL) clearance. The aim of this study …

If undiagnosed and untreated, familial hypercholesterolemia can lead to serious cardiac
complications, such as premature atherosclerotic cardiovascular disease. NPs should be …

Résumé Introduction L'hypercholestérolémie familiale hétérozygote (HF) est l'une des
maladies génétiques les plus fréquentes avec une incidence de l'ordre de 1/250. Elle est …

Résumé Contexte L'hypercholestérolémie familiale est une dyslipidémie héréditaire
monogénique (autosomique dominante) caractérisée par une augmentation permanente et …